ConductScience.org, home

Paper39337706

Novel Insights into Diabetic Kidney Disease.

Młynarska E and 8 others. Int J Mol Sci, 2024. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Novel Insights into Diabetic Kidney Disease. Papers, record 39337706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel Insights into Diabetic Kidney Disease.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
18.98, provisional
iCite
Revised in PubMed
2024-09-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Młynarska EEwelinahttps://orcid.org/0000-0002-6799-4746
2Buławska DDominika
3Czarnik WWitoldhttps://orcid.org/0009-0002-5502-0335
4Hajdys JJoannahttps://orcid.org/0009-0008-6892-6199
5Majchrowicz GGabrielahttps://orcid.org/0009-0007-0447-8510
6Prusinowski FFilip
7Stabrawa MMagdalenahttps://orcid.org/0009-0005-3490-3480
8Rysz JJacek
9Franczyk BBeata

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetic NephropathiesMajor topic
Humans
Diabetes Mellitus, Type 2
Animals
Kidney Failure, Chronic
Biomarkers

References158

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138774257Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.J Diabetes Res2024https://conductscience.org/library/papers/38774257PubMed
228815461Drug-Induced Kidney Injury in the Elderly.Drugs Aging2017https://conductscience.org/library/papers/28815461PubMed
33496481510. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.Diabetes Care2022https://conductscience.org/library/papers/34964815PubMed
426519090Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.Clin Biochem2016https://conductscience.org/library/papers/26519090PubMed
535370636Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis.Front Pharmacol2022https://conductscience.org/library/papers/35370636PubMed
637800812Comprehensive advancements in the prevention and treatment of diabetic nephropathy: A narrative review.Medicine (Baltimore)2023https://conductscience.org/library/papers/37800812PubMed
729529172Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network.Fam Pract2018https://conductscience.org/library/papers/29529172PubMed
829622670Pharmacology behind Common Drug Nephrotoxicities.Clin J Am Soc Nephrol2018https://conductscience.org/library/papers/29622670PubMed
927088241Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.Ann Intern Med2016https://conductscience.org/library/papers/27088241PubMed
1027053146Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.Biometals2016https://conductscience.org/library/papers/27053146PubMed
1135889923Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease.Nutrients2022https://conductscience.org/library/papers/35889923PubMed
1229507945Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.Ann Intern Med2018https://conductscience.org/library/papers/29507945PubMed
1331264950Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial.Radiology2019https://conductscience.org/library/papers/31264950PubMed
1428033563The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.Redox Biol2017https://conductscience.org/library/papers/28033563PubMed
1535296039Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care.Clin Kidney J2022https://conductscience.org/library/papers/35296039PubMed
1619332456Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.N Engl J Med2009https://conductscience.org/library/papers/19332456PubMed
1712631367The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.Kidney Int2003https://conductscience.org/library/papers/12631367PubMed
1815746541Diabetic nephropathy: the proteinuria hypothesis.Am J Nephrol2005https://conductscience.org/library/papers/15746541PubMed
1935663316Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35663316PubMed
2021148304Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care.Clin Chem2011https://conductscience.org/library/papers/21148304PubMed

See all 158 referencesDownload CSV of references

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42978566Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems.Front Clin Diabetes Healthc2026https://conductscience.org/library/papers/42978566PubMed
42968987Dioscin Alleviates Diabetic Kidney Disease via Activation of the Nrf2/HO-1 Signaling Axis.Diabetes Metab Syndr Obes2026https://conductscience.org/library/papers/42968987PubMed
42921117Periostin in diabetic kidney disease: mechanistic insights, biomarkers, and therapeutic perspectives.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42921117PubMed
42920458Effects of liraglutide on blood pressure and renal function in patients with type 2 diabetic nephropathy: a meta-analysis of randomized controlled trials.Front Med (Lausanne)2026https://conductscience.org/library/papers/42920458PubMed
42871587Yishen Xiaoke Formula Delays Renal Fibrosis in Rats with Diabetic Nephropathy by Suppressing the Transforming Growth Factor-Beta 1/Notch Signalling Pathway.Iran J Pharm Res2026https://conductscience.org/library/papers/42871587PubMed
42862833Effectiveness of a self-management intervention on clinical outcomes among patients with type 2 diabetes at high risk for Diabetic Kidney Disease: A Randomised Controlled Trial.PLoS One2026https://conductscience.org/library/papers/42862833PubMed
42788405Blood pressure targets for hypertension in people with diabetes mellitus.Cochrane Database Syst Rev2026https://conductscience.org/library/papers/42788405PubMed
42640759Dual roles of renal tubular mitochondrial Akt1 in protecting against diabetic nephropathy and improving body glucose metabolism.J Endocrinol2026https://conductscience.org/library/papers/42640759PubMed
42525323Global burden and future trends of type 2 diabetes mellitus-associated chronic kidney disease: analysis of the Global Burden of Disease Study 2021.Int J Clin Pharm2026https://conductscience.org/library/papers/42525323PubMed
42453508Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42453508PubMed
42444645Expression and Significance of Protein Arginine Methyltransferase 1 in the Serum of Patients with Diabetes Kidney Disease.Diabetes Metab Syndr Obes2026https://conductscience.org/library/papers/42444645PubMed
42422087The dysregulated unfolded protein response in diabetic kidney disease: mechanisms and crosstalk with cell death pathways.Front Pharmacol2026https://conductscience.org/library/papers/42422087PubMed
42416898Regulatory networks of post-translational modifications in diabetic kidney disease: from pathogenic mechanisms to therapeutic frontiers.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42416898PubMed
42395184Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42395184PubMed
42393799Dysregulation of the miR-4286 in diabetic kidney disease and its role in inflammatory response.Diabetol Metab Syndr2026https://conductscience.org/library/papers/42393799PubMed
42359004Periodontitis as a potential amplifier of diabetes-related genitourinary complications: evidence gradients and mechanistic insights into the inflammation-microvascular injury axis.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42359004PubMed
42310331KNG-1, HSPG and Robo4 reflect hypertension-driven subclinical renal alterations and provide incremental diagnostic value in type 2 diabetic nephropathy.Sci Rep2026https://conductscience.org/library/papers/42310331PubMed
42294076Virgin Coconut Oil Attenuates Diabetic Kidney Disease via Gut Microbiota-Metabolism-Inflammation Axis Modulation in Type 2 Diabetic Mice.Food Sci Nutr2026https://conductscience.org/library/papers/42294076PubMed
42279544Multimodal Magnetic Resonance Imaging in Diabetic Kidney Disease: From Pathophysiological Insights to Clinical Applications.Diagnostics (Basel)2026https://conductscience.org/library/papers/42279544PubMed
42220095Morphological and Biochemical Insights Into the Renoprotective Effects of Combined N-Acetylcysteine and Glycine Treatment in Experimental Diabetic Nephropathy.Pharmacol Res Perspect2026https://conductscience.org/library/papers/42220095PubMed

See all 77 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39337706

GET https://conductscience.org/api/papers/v1/39337706/references?page=2